Business Description
Albert Labs International Corp
NAICS : 541714
SIC : 3741
ISIN : CA0127841041
Compare
Compare
Traded in other countries / regions
ABRT.CanadaVB50.Germany IPO Date
2022-03-30Description
Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | -2.59 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 14-Day RSI | 46.61 | |||||
| 6-1 Month Momentum % | -44.44 | |||||
| 12-1 Month Momentum % | 25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.15 | |||||
| Quick Ratio | 0.15 | |||||
| Cash Ratio | 0.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -88.71 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -63.45 | |||||
| ROA % | -33.67 | |||||
| ROIC % | -105.62 | |||||
| ROC (Joel Greenblatt) % | -186.52 | |||||
| ROCE % | -63.37 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.97 | |||||
| EV-to-EBITDA | -0.98 | |||||
| EV-to-FCF | -1.43 | |||||
| Earnings Yield (Greenblatt) % | -103.09 | |||||
| FCF Yield % | -72.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Albert Labs International Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.09 | ||
| Beta | 0 | ||
| Volatility % | 172.98 | ||
| 14-Day RSI | 46.61 | ||
| 14-Day ATR (€) | 0.000007 | ||
| 20-Day SMA (€) | 0.005 | ||
| 12-1 Month Momentum % | 25 | ||
| 52-Week Range (€) | 0.002 - 0.014 | ||
| Shares Outstanding (Mil) | 74.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Albert Labs International Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Albert Labs International Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Albert Labs International Corp Frequently Asked Questions
What is Albert Labs International Corp(FRA:VB50)'s stock price today?
The current price of FRA:VB50 is €0.01. The 52 week high of FRA:VB50 is €0.01 and 52 week low is €0.00.
When is next earnings date of Albert Labs International Corp(FRA:VB50)?
The next earnings date of Albert Labs International Corp(FRA:VB50) is .
Does Albert Labs International Corp(FRA:VB50) pay dividends? If so, how much?
Albert Labs International Corp(FRA:VB50) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers